Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic-Associated Steatotic Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07093346
What this trial is testing

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+7 more
University of Nottingham 45
Not applicableLooking for participantsNCT07476703
What this trial is testing

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Who this might be right for
Coronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more
Danderyd Hospital 1,400
Not applicableNot Yet RecruitingNCT07834905
What this trial is testing

Nutritional Indices and Inflammatory Markers in MASLD

Who this might be right for
Liver FibrosisMalnutritionNon-Alcoholic Fatty Liver Disease
Assiut University 180
Not applicableStudy completedNCT07791589
What this trial is testing

Fibrosis and Metabolic Markers in Relation to PREVENT Cardiovascular Risk in MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Özgür Bahadır 271
Not applicableNot Yet RecruitingNCT07640880
What this trial is testing

Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV

Who this might be right for
MASLDHIV (Human Immunodeficiency Virus)
Yinzhong Shen 120
Not applicableEnrolling By InvitationNCT07592013
What this trial is testing

Effect of Ancestry Supplementation in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
MASLD
University of Guadalajara 60
Not applicableNot Yet RecruitingNCT07706010
What this trial is testing

Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

Who this might be right for
Type 2 Diabetes (T2DM)Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University 7,000
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableNot Yet RecruitingNCT07716995
What this trial is testing

Association Between Metabolic Associated Fatty Liver Disease and Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaMetabolic Dysfunction-Associated Steatotic Liver Disease
Assiut University 127
Not applicableNot Yet RecruitingNCT07487571
What this trial is testing

MPV as a Predictor for ACS in Patients With MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseAcute Coronary Syndromes (ACS)
Sohag University 60
Not applicableNot Yet RecruitingNCT07585526
What this trial is testing

Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Who this might be right for
MASLDChronic Kidney Diseases
Institute of Liver and Biliary Sciences, India 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631637
What this trial is testing

Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Regeneron Pharmaceuticals 150
Testing effectiveness (Phase 2)Study completedNCT06140953
What this trial is testing

Benefits of Trimetazidine in MASLD Patients

Who this might be right for
Metabolic Associated Fatty Liver Disease
October 6 University 60
Not applicableNot Yet RecruitingNCT07386665
What this trial is testing

Impact of Circadian Exercise on Metabolic Dysfunction-Associated Steatotic Liver Disease in Postmenopausal Women

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseCardiometabolic DiseasesExercise
Universidad de Almeria 63
Testing effectiveness (Phase 2)Looking for participantsNCT05519475
What this trial is testing

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Who this might be right for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Regeneron Pharmaceuticals 120
Not applicableStudy completedNCT07073326
What this trial is testing

Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNormobaric Hypoxia
University of Trieste 16
Next Page
114